SCHEMBL13065744

SCHEMBL13065744

COc1c2oc3ccccc3nc-2c(C(=O)O)c(-c2ccccc2)c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.48
ABCB1 P08183 1/20 0.44
LMNA P02545 2/20 0.43
MAPT P10636 5/20 0.43
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 4/20 0.43
HPGD P15428 3/20 0.43
HSD17B10 Q99714 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
CYP3A4 P08684 2/20 0.43
TSHR P16473 2/20 0.43
THRB P10828 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
DHODH Q02127 1/20 0.42
ADORA3 P0DMS8 1/20 0.41
ABCC1 P33527 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065736 0.94 BCL9 (0.44) ABCG2ABCB1LMNAMAPTALDH1A1
SCHEMBL13065739 0.94 ALDH1A1 (0.44) ABCG2ABCB1LMNAMAPTALDH1A1
SCHEMBL13065730 0.94 ABCG2 (0.50) ABCG2LMNAMAPTALDH1A1KDM4E
SCHEMBL13065741 0.93 DHODH (0.47) ABCG2ABCB1MAPTALDH1A1KDM4E
SCHEMBL13065742 0.91 KDM4E (0.47) ABCG2ABCB1LMNAMAPTALDH1A1
SCHEMBL13065734 0.91 SMN1; SMN2 (0.40) ABCG2ABCB1MAPTALDH1A1KDM4E
SCHEMBL13065743 0.90 KDM4E (0.40) ABCG2ABCB1LMNAMAPTALDH1A1
SCHEMBL13065745 0.90 ABCG2 (0.39) ABCG2ABCB1LMNAMAPTALDH1A1
SCHEMBL13065587 0.86 CASP3 (0.41) ABCG2ABCB1LMNAMAPTALDH1A1
SCHEMBL13065731 0.83 DHODH (0.47) ABCG2ABCB1LMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 ABCG2 1063/4885ABCB1 2390/4885LMNA 4171/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 ABCG2 1063/4885ABCB1 2390/4885LMNA 4171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.